Dexterra Group (DXT) Q3 2024 earnings summary

Executive summary

• Q3 2024 delivered strong results, with revenue rising 1.5% year-over-year to $269.7 million and 6.4% sequentially, driven by organic growth, robust WAFES activity, IFM expansion, and the CMI acquisition.

• Adjusted EBITDA was $32.0 million, down from $38.2 million in Q3 2023 but up from $29.3 million in Q2 2024, reflecting normalized wildfire activity.

• Sale of the Modular Solutions business closed August 30, 2024, simplifying operations and enabling a focus on core support services and asset-based businesses.

• IFM margins improved, with a healthy sales pipeline in both Canada and the U.S., and a focus on profitable organic growth and disciplined acquisitions.

• The company is well positioned for future growth, supported by a strong balance sheet and a supportive major shareholder.

Financial highlights

• Q3 2024 consolidated revenue was $269.7 million, up 1.5% year-over-year and 6.4% sequentially from Q2.

• Adjusted EBITDA for Q3 was $32.0 million, down from $38.2 million in Q3 2023 but up from $29.3 million in Q2.

• Free cash flow in Q3 was $11.9 million, an improvement from $10.2 million in Q3 2023.

• Debt at September 30, 2024, was approximately one times Adjusted EBITDA ($102.2 million), down from $139.8 million at Q2, mainly due to proceeds from the modular business sale.

• Net earnings from continuing operations were $13.4 million, with EPS from continuing operations at $0.21.

Outlook and guidance

• IFM Adjusted EBITDA margins are expected to remain above 6% into Q4 2024 and fiscal 2025, supported by labor cost management and acquisitions.

• Annualized organic growth in IFM is projected at about 6% for 2024, with a healthy sales pipeline in both Canada and the U.S.

• WAFES Adjusted EBITDA margin is expected to exceed 15% on an annualized basis, supported by high asset utilization and long-term contracts.

• Return on equity targeted at 15% in the near term, with continued focus on profitable growth and market share gains.

• Adjusted EBITDA to Free Cash Flow conversion expected to exceed 50% annually, with Q4 as the strongest quarter due to seasonality.